2024 Feb 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
PMID:32965842
Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome).
Strassburg CP.
Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):555-71. doi: 10.1016/j.bpg.2010.07.007.
PMID:20955959
Gene Therapy in Patients with the Crigler-Najjar Syndrome.
D'Antiga L, Beuers U, Ronzitti G, Brunetti-Pierri N, Baumann U, Di Giorgio A, Aronson S, Hubert A, Romano R, Junge N, Bosma P, Bortolussi G, Muro AF, Soumoudronga RF, Veron P, Collaud F, Knuchel-Legendre N, Labrune P, Mingozzi F.
N Engl J Med. 2023 Aug 17;389(7):620-631. doi: 10.1056/NEJMoa2214084.
PMID:37585628
Management of Crigler-Najjar syndrome.
Tcaciuc E, Podurean M, Tcaciuc A.
Med Pharm Rep. 2021 Aug;94(Suppl No 1):S64-S67. doi: 10.15386/mpr-2234. Epub 2021 Aug 10.
PMID:34527915
Crigler-Najjar Syndrome: Current Perspectives and the Application of Clinical Genetics.
Ebrahimi A, Rahim F.
Endocr Metab Immune Disord Drug Targets. 2018;18(3):201-211. doi: 10.2174/1871530318666171213153130.
Crigler-Najjar Syndrome Type 1: Pathophysiology, Natural History, and Therapeutic Frontier.
Strauss KA, Ahlfors CE, Soltys K, Mazareigos GV, Young M, Bowser LE, Fox MD, Squires JE, McKiernan P, Brigatti KW, Puffenberger EG, Carson VJ, Vreman HJ.
Hepatology. 2020 Jun;71(6):1923-1939. doi: 10.1002/hep.30959. Epub 2020 Feb 5.